15
Apr

Berkeley, CA’s Aduro Biotech banked $119 million in an upsized IPO with plans to hit the gas on its pipeline of treatments that use the body’s immune system to battle cancer.

…read more

Source: Aduro pulls off a $119M IPO to fund its immuno-oncology pipeline

    

0 No comments